3D structures of hypoxia-inducible factor
From Proteopedia
(Difference between revisions)
(New page: ==3D structures of hypoxia-inducible factor== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *HIF-1α; Human domai...) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 10: | Line 10: | ||
**[[1l3e]] – hHIF-1 CTAD + P300<br /> | **[[1l3e]] – hHIF-1 CTAD + P300<br /> | ||
**[[4zpr]] – hHIF-1 + ARNT + DNA<br /> | **[[4zpr]] – hHIF-1 + ARNT + DNA<br /> | ||
| + | **[[9of0]], [[9of2]], [[9ofu]] – hHIF-1 + ARNT + DNA – Cryo EM<br /> | ||
**[[4h6j]] – hHIF-1 PAS-B (mutant) + ARNT <br /> | **[[4h6j]] – hHIF-1 PAS-B (mutant) + ARNT <br /> | ||
| Line 19: | Line 20: | ||
**[[4pky]] – hARNT C-terminal PAS + HIF-2 peptide + ARNT-interacting protein<br /> | **[[4pky]] – hARNT C-terminal PAS + HIF-2 peptide + ARNT-interacting protein<br /> | ||
**[[4lpz]] – hARNT C-terminal PAS + coactivator<br /> | **[[4lpz]] – hARNT C-terminal PAS + coactivator<br /> | ||
| + | **[[8g4a]] – hARNT C-terminal PAS + tetrazole derivative<br /> | ||
| + | **[[8k71]], [[8k72]], [[8k73]] – hARNT C-terminal PAS + thiazole derivative<br /> | ||
**[[4gs9]] – hARNT C-terminal PAS (mutant) + HIF-2 peptide <br /> | **[[4gs9]] – hARNT C-terminal PAS (mutant) + HIF-2 peptide <br /> | ||
| + | **[[5tbm]] – hARNT C-terminal PAS + EPAS-1<br /> | ||
| + | **[[5v0l]] – hARNT 70-345 + mAHR + DNA<br /> | ||
**[[4zp4]], [[4zpk]] – mARNT + mHIF-2 - mouse<br /> | **[[4zp4]], [[4zpk]] – mARNT + mHIF-2 - mouse<br /> | ||
| + | **[[7w80]] – mARNT + mHIF-2 + drug<br /> | ||
| + | **[[5nj8]] – mARNT 85-345 + AHR + DNA<br /> | ||
| + | **[[7vni]] – mARNT 85-345 + DmAHR <br /> | ||
| + | **[[7v7l]], [[7v7w]] – mARNT + mHIF-3 <br /> | ||
| + | **[[5sy5]] – mARNT + NPAS1<br /> | ||
| + | **[[5sy7]] – mARNT + NPAS3 + DNA <br /> | ||
| + | **[[7xhv]], [[7xi4]] – mARNT + NPAS4 + DNA <br /> | ||
*HIF-2α or endothelial PAS domain-containing protein | *HIF-2α or endothelial PAS domain-containing protein | ||
| Line 26: | Line 38: | ||
**[[1p97]] – hHIF-2 C-terminal PAS - NMR<br /> | **[[1p97]] – hHIF-2 C-terminal PAS - NMR<br /> | ||
**[[5kiz]] – hHIF-2 PAS-B – NMR<br /> | **[[5kiz]] – hHIF-2 PAS-B – NMR<br /> | ||
| - | **[[3f1n]], [[3f1o]], [[ | + | **[[3f1n]], [[3f1o]], [[3f1p]], [[3h7w]], [[3h82]], [[4ghi]], [[6d0c]] – hHIF-2 PAS-B (mutant) + ARNT <br /> |
**[[6czw]], [[6d09]], [[6d0b]], [[6x21]], [[6x28]], [[6x2h]], [[6x37]], [[6x3d]] – hHIF-2 PAS-B (mutant) + ARNT + inhibitor<br /> | **[[6czw]], [[6d09]], [[6d0b]], [[6x21]], [[6x28]], [[6x2h]], [[6x37]], [[6x3d]] – hHIF-2 PAS-B (mutant) + ARNT + inhibitor<br /> | ||
**[[2a24]] – hHIF-2 PAS-B (mutant) + ARNT C-terminal PAS - NMR<br /> | **[[2a24]] – hHIF-2 PAS-B (mutant) + ARNT C-terminal PAS - NMR<br /> | ||
| Line 34: | Line 46: | ||
**[[4zqd]], [[6e3t]] – mHIF-2 + ARNT + inhibitor<br /> | **[[4zqd]], [[6e3t]] – mHIF-2 + ARNT + inhibitor<br /> | ||
**[[6e3u]] – mHIF-2 (mutant) + ARNT + agonist<br /> | **[[6e3u]] – mHIF-2 (mutant) + ARNT + agonist<br /> | ||
| + | |||
| + | *HIF-3 | ||
| + | |||
| + | **[[4wn5]] – hHIF-3 C-terminal PAS-B <br /> | ||
}} | }} | ||
| + | [[Category:Topic Page]] | ||
Current revision
3D structures of hypoxia-inducible factor
Updated on 17-September-2025
